Genetic determinants of depression: Recent findings and future directions

Harvard Review of Psychiatry

Volumn 23, Issue 1, 2015, Pages 1-18

  Dunn, Erin C ^a,b   Brown, Ruth C ^d   Dai, Yael ^b   Rosand, Jonathan ^b,c   Nugent, Nicole R ^e   Amstadter, Ananda B ^d   Smoller, Jordan W ^a,b,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e BROWN UNIVERSITY   (United States)

^f HARVARD UNIVERSITY   (United States)

Author keywords

Copy number variant; Depression; Gene environment interaction; Genetics; Genome wide association study; Genome wide environment interaction study; Rare variants

Indexed keywords

ALLELE; COPY NUMBER VARIATION; DEPRESSION; ENVIRONMENTAL EXPOSURE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LOSS OF FUNCTION MUTATION; NEXT GENERATION SEQUENCING; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE VESICLE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY;

DEPRESSION; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS;

EID: 84927712813     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1097/HRP.0000000000000054     Document Type: Review

References (162)

1. Merikangas KR, He S, Burstein M, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 2011;49:980-9.
2. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593-602.
3. Mathers C, Ma Fat D, Boerma JT. The global burden of disease: 2004 update. Geneva, Switzerland: World Health Organization, 2008.
4. Wang PA, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:629-40.
5. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
6. Driessen E, Van HL, Don FJ, et al. The efficacy of cognitive behavioral therapy and psychdynamic therapy in the outpatient treatment of major depression: A randomized clinical trial. Am J Psychiatry 2013;170:1041-50.
7. Rush AJ, Trivedi M, Fava M. Depression, IV: STAR∗D treatment trial for depression. Am J Psychiatry 2003;160:237.
8. Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. The STAR∗D project results: A comprehensive review of findings. Curr Psychiatry Rep 2007;9:449-59.
9. Cox GR, Callahan P, Churchill R, et al. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Syst Rev 2012;11:CD008324.
10. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: A meta-analysis. Psychol Bull 2006;132:132-49.
11. Weisz JR, Kuppens S, Eckshtain D, Ugueto AM, Hawley KM, Jensen-Doss A. Performance of evidence-based youth psychotherapies compared with usual clinical care: A multilevel meta-analysis. JAMA Psychiatry 2013;70:750-61.
12. Kessler RC, Zhao S, Blazer DG. Prevalence, course, and correlates of minor andMDD in the National Comorbidity Survey. J Affect Disord 1997;45:19-30.
13. Brooks-Gunn J, Duncan GJ. The effects of poverty on children. Future Child 1997;7:55-71.
14. McLeod JD, Shanahan MJ. Trajectories of poverty and children's mental health. J Health Soc Behav 1996;37:207-20.
15. Repetti RL, Taylor SE, Seeman TE. Risky families: Family social environments and the mental and physical health of offspring. Psychol Bull 2002;128:330-66.
16. Gilman SE, Kawachi I, Fitzmaurice GM, Buka SL. Family disruption in childhood and risk of adult depression. Am J Psychiatry 2003;160:939-46.
17. Slopen N, Koenen KC, Kubzansky LD. Cumulative adversity in childhood and emergent risk factors for long-term health. J Pediatr 2014;164:631-8.
18. Widom CS, DuMont K, Czaja SJ. A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up. Arch Gen Psychiatry 2007;64:49-56.
19. Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol 1997;48:191-214.
20. Hammen C. Stress and depression. Annu Rev Clin Psychol 2005;1:293-319.
21. Dunn EC, Gilman SE, Slopen N, Willett JB, Molnar BE. The impact of exposure to interpersonal violence on gender differences in adolescent-onset major depression: results from the National Comorbidity Survey Replication (NCS-R). Depress Anxiety 2012;29:392-9.
22. Dunn EC, McLaughlin KA, Slopen N, Rosand J, Smoller JW. Developmental timing of child maltreatment and symptoms of depression and suicidality in young adulthood: results from the National Longitudinal Study of Adolescent Health. Depress Anxiety 2013;30:955-64.
23. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta analysis. Am J Psychiatry 2000;157:1552-62.
24. Rice F, Harold G, Thapar A. The genetic aetiology of childhood depression: A review. J Child Psychol Psychiatry 2002;43:65-79.
25. Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 2007; 64:327-37.
26. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 1994;40:288-95.
27. Thase ME, ed. Neurobiological aspects of depression. 2nd ed. New York: Guilford, 2009.
28. Levinson DF. The genetics of depression: A review. Biol Psychiatry 2006;60:84-92.
29. Lohoff FW. Overview of the genetics ofmajor depressive disorder. Curr Psychiatry Rep 2010;12:539-46.
30. Hettema JM. Genetics of depression. Focus 2010;8:316-22.
31. Shyn SI, Hamilton SP. The genetics of major depression: Moving beyond the monoamine hypothesis. Psychiatr Clin North Am 2010;33:125-40.
32. Cohen-Woods S, Craig IW, McGuffin P. The current state of play on the molecular genetics of depression. Psychol Med 2012;43:673-87.
33. Saveanu RV, Nemeroff CB. Etiology of depression: genetic and environmental factors. Psychiatr Clin North Am 2012;35: 51-71.
34. Perlis RH. Pharmacogenomic testing and personalized treatment of depression. Clin Chem 2014;60:53-9.
35. Attia J, Ioannidis JP, Thakkinstian A, et al. How to use an article about genetic association: background concepts. JAMA 2009;301:74-81.
36. Attia J, Ioannidis JP, Thakkinstian A, et al. How to use an article about genetic association: Are the results of the study valid? JAMA 2009;301:191-7.
37. Corvin A, Craddock N, Sullivan PF. Genome-wide association studies: A primer. Psychol Med 2010;40:1063-77.
38. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010;36:166-76.
39. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006;7:781-91.
40. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008;299:1335-44.
41. National Human Genome Research Institute. A catalog of published genome-wide association studies. 2013. At http://www.genome.gov/gwastudies.
42. Sullivan PF, de Geus EJ, Willemsen G, et al. Genome-wide association for major depressive disorder: A possible role for the presynaptic protein piccolo. Mol Psychiatry 2009; 14:359-75.
43. Rietschel M, Mattheisen M, Frank J, et al. Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol Psychiatry 2010;68:578-85.
44. Terracciano A, Tanaka T, Sutin AR, et al. Genome-wide association scan of trait depression. Biol Psychiatry 2010;68: 811-7.
45. Muglia P, Tozzi F, Galwey NW, et al. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 2010;15:589-601.
46. Lewis CM, Ng MY, Butler AW, et al. Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry 2010;167:949-57.
47. Shi J, Potash JB, Knowles JA, et al. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 2011;16:193-201.
48. Aragam N, Wang KS, Pan Y. Genome-wide association analysis of gender differences in major depressive disorder in the Netherlands NESDA and NTR population-based samples. J Affect Disord 2011;133:516-21.
49. Kohli MA, Lucae S, Saemann PG, et al. The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 2011;70:252-65.
50. Shyn SI, Shi J, Kraft JB, et al. Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies. Mol Psychiatry 2011;16:202-15.
51. Wray NR, Pergadia ML, Blackwood DH, et al. Genome-wide association study of major depressive disorder: new results, metaanalysis, and lessons learned. Mol Psychiatry 2012;17:36-48.
52. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S, Wray NR, Lewis CM, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013;18:497-511.
53. Power RA, Keers R, Ng MY, et al. Dissecting the genetic heterogeneity of depression through age at onset. Am J Med Genet B Neuropsychiatr Genet 2012;159B:859-68.
54. Luciano M, Huffman JE, Arias-Vasquez A, et al. Genome-wide association uncovers shared genetic effects among personality traits and mood states. Am J Med Genet B Neuropsychiatr Genet 2012;159B:684-95.
55. Hek K, Demirkan A, Lahti J, et al. A genome-wide association study of depressive symptoms. Biol Psychiatry 2013;73:667-78.
56. Power RA, Cohen-Woods S, Ng MY, et al. Genome-wide association analysis accounting for environmental factors through propensity-score matching: Application to stressful live events in major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 2013;162B:521-9.
57. Hek K, Mulder CL, Luijendijk HJ, et al. The PCLO gene and depressive disorders: replication in a population-based study. Hum Mol Genet 2010;15:731-4.
58. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty, and challenges. Nat Rev Genet 2008;9:356-69.
59. Donnelly P. Progress and challenges in genome-wide association studies in humans. Nature 2008;456:728-31.
60. Psychiatric GWAS Consortium Coordinating Committee. Genomewide association studies: History, rationale, and prospects for psychiatric disorders. Am J Psychiatry 2009;166:540-56.
61. Sullivan PF. The Psychiatric GWAS Consortium: big science comes to psychiatry. Neuron 2010;68:182-6.
62. Psychiatric GWAS Consortium Steering Committee. A framework for interpreting genome-wide association studies of psychiatric disorders. Mol Psychiatry 2009;14:10-7.
63. Logue MW, Baldwin C, Guffanti G, et al. A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol Psychiatry 2013;18:937-42.
64. Lopez-Leon S, Janssens AC, Gonzalez-Suloeta Ladd AM, et al. Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 2008;13:772-85.
65. Lopez-Leon S, Croes EA, Sayed-Tabatabaei FA, Claes SJ, Van Broeckhoven C, van Duijn CM. The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: A meta analysis. Biol Psychiatry 2005;57:999-1003.
66. Haenisch B, Herms S, Mattheisen M, et al. Genome-wide association data provide further support for an association between 5-HTTLPR and major depressive disorder. J Affect Disord 2013;146:438-40.
67. Vinkhuyzen AA, Dumenil T, Ryan L, et al. Identification of tag haplotypes for 5HTTLPR for different genome-wide SNP platforms. Mol Psychiatry 2011;16:1073-5.
68. Moffitt TE, Caspi A, Rutter M. Strategy for investigating interactions between measured genes and measured environments. Arch Gen Psychiatry 2005;62:473-81.
69. Moffitt TE, Caspi A, Rutter M. Measured gene-environment interactions in psychopathology: concepts, research strategies, and implications for research, intervention, and public understanding of genetics. Perspect Psychol Sci 2006;1:5-27.
70. Dunn EC, Uddin M, Subramanian SV, Smoller JW, Galea S, Koenen KC. Gene-environment interaction (G-E) research in youth depression: A systematic review with recommendations for future research. J Child Psychol Psychiatry 2011;52: 1223-38.
71. Monroe SM, Simons AD. Diathesis-stress theories in the context of life stress research: Implications for the depressive disorders. Psychol Bull 1991;110:406-25.
72. Bakermans-KranenburgMJ, Van IMH, Pijlman FT, Mesman J, Juffer F. Experimental evidence for differential susceptibility: Dopamine D4 receptor polymorphism (DRD4 VNTR) moderates intervention effects on toddlers' externalizing behavior in a randomized controlled trial. Dev Psychol 2008;44:293-300.
73. Brody GH, Beach SR, Philibert RA, Chen YF, Murry VM. Prevention effects moderate the association of 5-HTTLPR and youth risk behavior initiation: gene x environment hypotheses tested via a randomized prevention design. Child Dev 2009;80: 645-61.
74. Belsky J, Pleuss M. Beyond diathesis stress: Differential susceptibility to environmental influences. Psychol Bull 2009;135: 885-908.
75. Ellis BJ, Boyce WT. Biological sensitivity to context. Curr Dir Psychol Sci 2008;17:183-7.
76. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-9.
77. Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, Anda RF. Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord 2004;82: 217-25.
78. McLaughlin KA, Greif Green J, Gruber MJ, Sampson NA, Zaslavsky AM, Kessler RC. Childhood adversities and adult psychiatric disorders in the National Comorbidity Survey Replication II: Associations with persistence of DSM-IV disorders. Arch Gen Psychiatry 2010;67:124-32.
79. Nugent NR, Tyrka AR, Carpenter LL, Price LH. Geneenvironment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology (Berl) 2011; 214:175-96.
80. Risch N, Herrell R, Lehner T, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: A meta analysis. JAMA 2009;301:2462-71.
81. Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011;68:444-54.
82. Uher R, McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the aetiology ofmental illness: review and methodological analysis. Mol Psychiatry 2008;13:131-46.
83. Uher R, McGuffin P. The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry 2010;15:18-22.
84. Munafo MR, Durrant C, Lewis G, Flint J. Gene Xenvironment interactions at the serotonin transporter locus. Biol Psychiatry 2009;65:211-9.
85. Brown GW, Harris TO. Depression and the serotonin transporter 5-HTTLPR polymorphism: A review and a hypothesis concerning gene-environment interaction. J Affect Disord 2008;111:1-12.
86. Wankerl M, Wust S, Otte C. Current developments and controversies: Does the serotonin transporter gene-linked polymorphic region (5-HTTLPR) modulate the association between stress and depression? Curr Opin Psychiatry 2010;23:582-7.
87. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic sensitivity to the environment: The case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010;167:1-19.
88. Kaufman J, Gelernter J, Kaffman A, Caspi A, Moffitt T. Arguable assumptions, debatable conclusions. Biol Psychiatry 2010; 67:e19-e20.
89. Munafo MR, Durrant C, Lewis G, Flint J. Defining replication: A response to Kaufman and colleagues. Biol Psychiatry 2010; 67:e21-3.
90. Duncan LE, Pollastri AR, Smoller JW. Mind the gap: why many geneticists and psychological scientists have discrepant views about gene-environment interaction (G-E) research. Am Psychol 2014;69:249-68.
91. Fergusson DM, Horwood LJ, Miller AL, Kennedy MA. Life stress, 5-HTTLPR and mental disorder: Findings from a 30- year longitudinal study. Br J Psychiatry 2011;198:129-35.
92. Munafo MR. The serotonin transporter gene and depression. Depress Anxiety 2012;29:915-7.
93. Appel K, Schwahn C, Mahler J, et al. Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 2011;36:1982-91.
94. Bradley RG, Binder EB, Epstein MP, et al. Influence of child abuse on adult depression: Moderation by the corticotropinreleasing hormone receptor gene. Arch Gen Psychiatry 2008; 65:190-200.
95. Lavebratt C, Aberg E, Sjoholm LK, Forsell Y. Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J Affect Disord 2010;125:249-55.
96. Zimmermann P, Brucki T, Nocon A, et al. Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective study. Am J Psychiatry 2011;168:1107-16.
97. Gillespie CF, Phifer J, Bradley B, Ressler KJ. Risk and resilience: genetic and environmental influences on development of the stress response. Depress Anxiety 2009;26:984-92.
98. Hosang G, Shiles C, Tansey KE, McGuffin P, Uher R. Interaction between stress and the BDNF Val66Met polymorphism in depression: A systematic review and meta-analysis. BMC Med 2014;12:7.
99. Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011;43:977-83.
100. Ferreira MA, O'Donovan MC, Meng Y, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008;40: 1056-8.
101. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011;43:969-76.
102. Nyegaard M, Demontis D, Foldager L, Hedemand A, Flint TJ, et al. CACNA1C (rs1006737) is associated with schizophrenia. Mol Psychiatry 2010;15:119-21.
103. Hamshere ML, Walters JT, Smith R, Richards AL, Green E, et al. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry 2013;18:708-12.
104. Ripke S, O'Dushlaine C, Chambert K, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013;45:1150-9.
105. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: A tool for genome-wide complex trait analysis. Am J Hum Genet 2011; 88:76-82.
106. Lubke GH, Hottenga JJ, Walters R, et al. Estimating the genetic variance of major depressive disorder due to all single nucleotide polymorphisms. Biol Psychiatry 2012;72:707-9.
107. Lee SH, Ripke S, Neale BM, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013;45:984-94.
108. Demirkan A, Penninx BW, Hek K, et al. Genetic risk profiles for depression and anxiety in adult and elderly cohorts. Mol Psychiatry 2011;16:773-83.
109. Wang K, Li M, Hakonarson H. Analysing biological pathways in genome-wide association studies. Nat Rev Genet 2010;11: 843-54.
110. Holmans P. Statistical methods for pathway analysis of genome-wide data for association with complex genetic traits. Adv Genet 2010;72:141-79.
111. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27-30.
112. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-9.
113. Lee PH, Perlis RH, Jung JY, et al. Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder. Transl Psychiatry 2012;2:e184.
114. Kao CF, Jia P, Zhao Z, Kuo PH. Enriched pathways for major depressive disorder identified from a genome-wide association study. Int J Neuropsychopharmacol 2012;15:1401-11.
115. Sanders SJ, Ercan-Sencicek AG, HusV, et al.Multiple recurrent de novo CNVs, including duplications of the 7q11.23Williams syndrome region, are strongly associated with autism. Neuron 2011;70:863-85.
116. Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science 2007;316: 445-9.
117. Stefansson H, Rujescu D, Cichon S, et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008;455:232-6.
118. Purcell SM, Moran JL, Fromer M, et al. Apolygenic burden of rare disruptivemutations in schizophrenia. Nature 2014;506:185-90.
119. Malhotra D, McCarthy S, Michaelson JJ, et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011;72:951-63.
120. Bras J, Guerreiro R, Hardy J. Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat Rev Neurosci 2012;12:453-64.
121. Rizzo JM, Buck MJ. Key principles and clinical applications of "next-generation" DNA sequencing. Cancer Prev Res (Phila) 2012;5:887-900.
122. Rucker JJ, Breen G, Pinto D, et al. Genome-wide association analysis of copy number variation in recurrent depressive disorder. Mol Psychiatry 2013;18:183-9.
123. Degenhardt F, Priebe L, Herms S, et al. Association between copy number variants in 16p11.2 and major depressive disorder in a German case-control sample. Am J Med Genet B Neuropsychiatr Genet 2012;159B:263-73.
124. Glessner JT, Wang K, Sleiman PM, et al. Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder. PLoS One 2010;5:e15463.
125. O'Duschlaine C, Ripke S, Ruderfer DM, et al. Rare copy number variation in treatment-resistant major depressive disorder. Biol Psychiatry 2014;76:536-41.
126. Wain LV, Armour JA, Tobin MD. Genomic copy number variation, human health, and disease. Lancet 2009;374:340-50.
127. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet 2010;11:259-72.
128. Thomas D. Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annu Rev Public Health 2010;31:21-36.
129. Wu C, Kraft P, Zhai K, et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet 2012;44:1090-7.
130. Seigert S, Hampe J, Schafmayer C, et al. Genome-wide investigation of gene-environment interactions in colorectal cancer. Hum Genet 2013;132:219-31.
131. Cornelis MC, Tchetgen EJ, Liang L, et al. Gene-environment interactions in genome-wide association studies: A comparative study of tests applied to empirical studies of type 2 diabetes. Am J Epidemiol 2012;175:191-202.
132. Manning AK, Hivert M-F, Scott RA, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012;44:659-69.
133. Hamza TH, Chen H, Hill-Burns EM, et al. Genome-wide gene environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet 2011;7:e1002237.
134. Hancock DB, ArtigasMS, Gharib SA, et al. Genome-wide joint meta analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. Plos Genet 2012;8: e1003098.
135. Beaty TH, Ruczinski I, Murray JC, et al. Evidence for gene environment interaction in a genome wide study of nonsyndromic cleft palate. Genet Epidemiol 2011;35:469-78.
136. Winham SJ, Biernacka JM. Gene-environment interactions in genome-wide association studies: current approaches and new directions. J Child Psychol Psychiatry 2013;54:1120-34.
137. Gauderman WJ, Zhang P, Morrison JL, Lewinger JP. Finding novel genes by testing G-E interactions in a genome-wide association study. Genet Epidemiol 2013;37:603-13.
138. Hutter CM, Mechanic LE, Chatterjee N, Kraft P, Gillanders EM; NCI Gene-Environment Think Tank. Gene-environment interactions in cancer epidemiology: A National Cancer Institute Think Tank report. Genet Epidemiol 2013;37:643-57.
139. Dunn EC, Masyn KE, Yudron M, Jones SM, Subramanian SV. Translating multilevel theory into multilevel research: challenge and opportunities for understanding the social determinants of psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol 2014;49:859-72.
140. Wild CP. The exposome: From concept to utility. Int J Epidemiol 2012;41:24-32.
141. Patel CJ, Bhattacharya J, Butte AJ. An environment-wide association study (EWAS) on type 2 diabetes mellitus. PLoS One 2010;5:e10746.
142. Galatzer-Levy IR, Bryant RA. 626, 120 ways to have posttraumatic stress disorder. Perspect Psychol Sci 2013;8:651-62.
143. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
144. Teicher MH, Samson JA. Childhood maltreatment and psychopathology: A case for ecophenotypic variants as clinically and neurobiologically distinct subtypes. Am J Psychiatry 2014;170:1114-33.
145. Nemeroff CB, Heim CM, Thase ME, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Natl Acad Sci 2003;100:14293-6.
146. Kendler KS, Aggen SH, Neale MC. Evidence for multiple genetic factors underlying DSM-IV criteria for major depression. JAMA Psychiatry 2013;70:599-607.
147. Kendler KS, Gardner CO. Boundaries of major depression: An evaluation of DSM-IV criteria. Am J Psychiatry 1998; 155:172-7.
148. Takayanagi Y, Spira AP, Roth KB, Gallo JJ, Eaton WW, Mojtabai R. Accuracy of reports of lifetime mental and physical disorders: results from the Baltimore Epidemiological Catchment Area Study. JAMA Psychiatry 2014;71: 272-80.
149. Plomin R, Haworth CMA, Davis OSP. Common disorders are quantitative traits. Nat Rev Genet 2009;10:872-8.
150. van Loo HM, de Jonge P, Romeijn JW, Kessler RC, Schoevers RA. Data-driven subtypes of major depressive disorder: A systematic review. BMC Med 2012;10:156.
151. Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 1996;53:391-9.
152. Lamers F, Burstein M, He J, Avenevoli S, Angst J, Merikangas KR. Structure of major depressive disorder in adolescents and adults in the US general population. Br J Psychiatry 2012;201: 143-50.
153. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003;160:636-45.
154. Mathews A, MacLeod C. Cognitive vulnerability to emotional disorders. Annu Rev Clin Psychol 2005;1:167-95.
155. Gotlib IH, Joormann J. Cognition and depression: current status and future directions. Annu Rev Clin Psychol 2010;6: 285-312.
156. Pizzagalli DA, Holmes AJ, Dillon DG, et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 2009;166:702-10.
157. Hasler G, Drevets WC, Manji HK, Charney DS. Discovering endophenotypes for major depression. Neuropsychopharmacology 2004;29:1765-81.
158. Sanislow CA, Pine DS, Quinn JP, et al. Developing constructs for psychopathology research: research domain criteria. J Abnorm Psychol 2010;4:631-9.
159. Morris SE, Cuthbert BN. Research domain criteria: cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin Neurosci 2012;14:29-37.
160. Craddock N, Owen MJ. The Kraepelinian dichotomy-going, going . . . but still not gone. Br J Psychiatry 2010;196:92-5.
161. Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. Am J Psychiatry 2010;167:748-51.
162. Stein JL, Medland SE, Vasquez AA, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 2012;44:552-61.